Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiaks Antibody Biopolymer Conjugate Platform
| KOD Stock | USD 6.40 0.40 5.88% |
About 62% of Kodiak Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Kodiak Sciences suggests that many traders are alarmed. The current market sentiment, together with Kodiak Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Kodiak Sciences stock news signals to limit their universe of possible portfolio assets.
Kodiak |
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that nine scientific presentations on its clinical and research pipeline programs will be made at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting, being held from May 5 9 in Seattle, Washington.
Read at finance.yahoo.com
 |
Kodiak Sciences Fundamental Analysis
We analyze Kodiak Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kodiak Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kodiak Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Kodiak Sciences is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Kodiak Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kodiak Sciences stock to make a market-neutral strategy. Peer analysis of Kodiak Sciences could also be used in its relative valuation, which is a method of valuing Kodiak Sciences by comparing valuation metrics with similar companies.
Peers
Kodiak Sciences Related Equities
| RVPHW | Reviva Pharmaceuticals | 25.00 | ||||
| STOK | Stoke Therapeutics | 4.46 | ||||
| GOSS | Gossamer Bio | 3.13 | ||||
| RVPH | Reviva Pharmaceuticals | 2.72 | ||||
| SPRO | Spero Therapeutics | 1.16 | ||||
| SRPT | Sarepta Therapeutics | 0.87 | ||||
| MDGL | Madrigal Pharmaceuticals | 1.03 | ||||
| BMEA | Biomea Fusion | 1.65 | ||||
| FBIOP | Fortress Biotech | 1.68 | ||||
| CKPT | Checkpoint Therapeutics | 1.73 | ||||
| AKRO | Akero Therapeutics | 2.31 | ||||
| ASMB | Assembly Biosciences | 2.91 | ||||
| CTMX | CytomX Therapeutics | 3.41 | ||||
| RNAZ | Transcode Therapeutics | 6.09 | ||||
| CGTX | Cognition Therapeutics | 6.49 | ||||
| MBIO | Mustang Bio | 7.89 | ||||
| TIL | Instil Bio | 8.74 |
Complementary Tools for Kodiak Stock analysis
When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |